$TROV News Article - Phase 1b/2 Dose Escalation Tr
Post# of 15376
(Total Views: 146)
Posted On: 04/01/2019 1:05:40 PM
$TROV News Article - Phase 1b/2 Dose Escalation Trial of Onvansertib in Relapsed/Refractory AML Demonstrates Safety, Tolerability and Relative Durability with Complete Responses at Highest Dose Levels https://marketwirenews.com/news-releases/phas...25332.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼